Detalhe da pesquisa
1.
Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension.
Eur Respir J;
55(4)2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32029443
2.
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.
J Pediatr;
223: 164-169.e1, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32711743
3.
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension.
ERJ Open Res;
7(4)2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34651041
4.
Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
J Am Heart Assoc;
10(20): e021409, 2021 10 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34622662
5.
Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.
Chest;
157(6): 1606-1616, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31987881